- U.S. Patent and Trademark Office Allows Non-Invasive Blood Glucose Monitoring Patent to Novanex Inc. [Jan. 15, 2014]
- List of Publications, Novanex Inc. [Jan. 15, 2014]
Novanex is a US-based medical device company that develops and commercializes innovative device and technology to monitor or detect disease conditions or status. Our first developmental product, NV100, monitors and displays the blood glucose level non-invasively in two minutes. The system is designed for use in hospitals as well as in outpatient sites and homes. NV100, is in the process of US regulatory filing, and has been tested in with high reliability and accuracy in several studies. Results indicate performance similar to those of invasive glucose sensors on the market today. The Company's products are based on its proprietary, patented Optimized Metabolic Calorimetry technology, which overcomes critical obstacles that hinder the performance of many competing approaches/technologies. Novanex has been granted a US patent (US 8,676,284) to protect its novel device, method, and algorithm.
Site & Facilities
Novanex Inc. is located at 675 US Highway One, Unit 130, North Brunswick, New Jersey. The laboratory is one of the modern bio-tech modules in the New Jersey state-owned Commercialization Center for Innovative Technologies, within the technology incubator complex of Technology Centre of New Jersey. The laboratory occupies about 1,000 sq. ft. floor space, and equipped with Class 10,000 clean room for GMP manufacturing of clinical trial materials/device prototypes. Novanex is one of 30 life-science companies reside in this science park.